Stephen Broderick

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding, Gad Getz, David A. Wheeler et al. · Nature · 2008 · 2.7K citations · Full text

Medicine, Genetics, Oncology +16

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith et al. · New England Journal of Medicine · 2018 · 2.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin‐Yuan Shih et al. · Proceedings of the National Academy of Sciences · 2007 · 1.6K citations

Medicine, Genetics, Oncology +17

Characterizing the cancer genome in lung adenocarcinoma

Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz et al. · Nature · 2007 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

Epigenetic therapy inhibits metastases by disrupting premetastatic niches

Zhihao Lü, Jianling Zou, Shuang Li et al. · Nature · 2020 · 337 citations · Full text

Medicine, Cancer Biology, Oncology +14